Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jan;15(1):14-21.
doi: 10.22122/arya.v15i1.1748.

Comparison of the incidence and severity of delirium and biochemical factors after coronary artery bypass grafting with dexmedetomidine: A randomized double-blind placebo-controlled clinical trial study

Gholamreza Massoumi  1 , Mojtaba Mansouri  2 , Shima Khamesipour  3
Affiliations

Comparison of the incidence and severity of delirium and biochemical factors after coronary artery bypass grafting with dexmedetomidine: A randomized double-blind placebo-controlled clinical trial study

Gholamreza Massoumi et al. ARYA Atheroscler. 2019 Jan.

Abstract

Background: One of the most common postoperative problems, such as open heart surgery, is delirium, which is responsible for increased mortality and morbidity. Therefore, it is necessary to find a way to cure this disease. The purpose of this study was to assess the effect of dexmedetomidine administration on the prevention of delirium after coronary artery bypass grafting (CABG) surgery.

Methods: This randomized double-blind placebo-controlled clinical trial was performed on 88 patients (44 in the intervention group and 44 in the control group) undertaking CABG surgery. The intervention group was subcutaneously treated with doses of 1 μg/kg of dexmedetomidine for 10 minutes, and 0.2-0.7 μg/kg in hour infusion was applied. The control group underwent normal saline infusion as a placebo. Chi-square and analysis of variance (ANOVA) tests were used to compare the data.

Results: Administration of dexmedetomidine in intervention group significantly decreased delirium (P = 0.040) and delirium intensity (P = 0.001). Moreover, patients treated with dexmedetomidine had more stability in laboratory variables and vital signs, and also the duration of hospitalization in these patients was significantly lower than control group (P = 0.002).

Conclusion: Considering the efficacy of dexmedetomidine on preventing the incidence and severity of delirium and reducing mortality and morbidity, it is recommended that another study with the larger sample size, with different doses and different prescribing methods be conducted to better understand the effect of this drug and achieve a safe dose with maximum efficacy.

Keywords: Coronary Artery Bypass Grafting; Delirium; Dexmedetomidine.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flowchart (CONSORT format)
See this image and copyright information in PMC

References

    1. Girard TD, Pandharipande PP, Ely EW. Delirium in the intensive care unit. Crit Care. 2008;12(Suppl 3):S3. - PMC - PubMed
    1. Ely EW, Stephens RK, Jackson JC, Thomason JW, Truman B, Gordon S, et al. Current opinions regarding the importance, diagnosis, and management of delirium in the intensive care unit: A survey of 912 healthcare professionals. Crit Care Med. 2004;32(1):106–12. - PubMed
    1. Mac Sweeney R, Barber V, Page V, Ely EW, Perkins GD, Young JD, et al. A national survey of the management of delirium in UK intensive care units. QJM. 2010;103(4):243–51. - PubMed
    1. Fricchione GL, Nejad SH, Esses JA, Cummings TJ, Querques J, Cassem NH, et al. Postoperative delirium. Am J Psychiatry. 2008;165(7):803–12. - PubMed
    1. Guenther U, Theuerkauf N, Frommann I, Brimmers K, Malik R, Stori S, et al. Predisposing and precipitating factors of delirium after cardiac surgery: A prospective observational cohort study. Ann Surg. 2013;257(6):1160–7. - PubMed

LinkOut - more resources